|
January 2012 - Seminars in Spine Surgery
Regulatory Challenges in Getting Total Disc Replacements Onto the Market in an Era of Increased Food and Drug Administration Scrutiny
November 2011 - RAPS Regulatory Focus
Coverage of IDE Clinical Trial Costs: Navigating the Medicare Maze
June 2011 - ABA Health eSource
A Historical Framework for Accountable Care Organizations:
Will CMS Meet Its Long-Term Goals with this Initiative?
July 2010 - Do Not Experiment with Clinical Trial Coding
May 2010 - Tracking Reimbursement and Payment Trends
Device firms with well-planned reimbursement strategies position themselves to secure market share and sales they might otherwise have lost.
May/June 2009 - Ortho Design & Tech
How Medicare Rule Would Impact Orthopedic Technology Firms
November 2008 - Ortho Design & Technology
Product Positioning and Reimbursement
September - October 2008 - Ortho Insights
CMS to Encourage Further Care Coordination and Quality Reporting
July 2008 - Gray Sheet
Expectations For Artificial Disc Trials Challenge Market Hopefuls
July 2008 - Gray Sheet
Artificial Disc Patent Case Could Define Shape of The Market
May 2008 - Orthopedic Design & Technology
Clinical Trial Reimbursement Integration and
Management
Spring 2008 - BONEZone
Executing Reimbursement Strategies for
Innovative Orthopaedic Technologies
March 2008 - Gray Sheet
Reimbursement is More Than Passing Thought For Spine Firm in FDA Trials
Volume 62, Number 3, 2007 - Food and Drug Law Journal
Medical Device Reporting: Issues with Class III Medical Devices
May 2007 - Orthopedics This Week
FDA Ortho Panel Recommends STAR Ankle PMA Approval –- With Elephant in the Room
November 2006 - New York Times
FDA Panel Supports Artificial Disks for Upper Spine |
